chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very bad rash from booster; Warm at injection site; Very swollen, arm all red; Itching near injection site/Itchy; Red at injection site; Swelling near injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Very bad rash from booster), VACCINATION SITE WARMTH (Warm at injection site), PERIPHERAL SWELLING (Very swollen, arm all red), VACCINATION SITE PRURITUS (Itching near injection site/Itchy) and VACCINATION SITE ERYTHEMA (Red at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy (Allergic to latex).   On 10-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced RASH (Very bad rash from booster), VACCINATION SITE WARMTH (Warm at injection site), PERIPHERAL SWELLING (Very swollen, arm all red), VACCINATION SITE PRURITUS (Itching near injection site/Itchy), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE SWELLING (Swelling near injection site). In November 2021, PERIPHERAL SWELLING (Very swollen, arm all red) had resolved. At the time of the report, RASH (Very bad rash from booster), VACCINATION SITE WARMTH (Warm at injection site), VACCINATION SITE PRURITUS (Itching near injection site/Itchy), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE SWELLING (Swelling near injection site) was resolving.            No concomitant medications were reported. The patient states the tape that was used to put over injection site may be the cause or contained latex, the itching had got better after removing the tape but still ongoing. Patient taken some medication for allergies (Pills) and the itching subsidized for a little while. It was very swollen before, and arm was all red. Patient said It was horrible itching. At the time of report,she said that it is itching a little, but not too much Patient mentioned that she had the previous 2 doses of the vaccines, and did not feel anything   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2021: Patient demographics and new events were added
Patient given MMR II on 2/10/15. Started with arthralgia on 2/19/15. 2/27/15 seen by MD with constant c/o arthralgias of knees, ankles, hands and elbow. Patient to take ADVIL and f/u in 1 week.
Adds that his wife is wanting to hold back on taking the second dose until the side effects; pain at injection site on the day of injection; joint pain; muscle pain; inflammation; swelling in hands and wrist; pain; This is a spontaneous report from a contactable consumer. A 67-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified (age at vaccination 67 years) date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced adds that his wife is wanting to hold back on taking the second dose until the side effects, on the day of injection pain at injection site on the day of injection, On the second day after the vaccine joint pain, muscle pain, inflammation, swelling in hands and wrist, pain. Reporter stated, her wife had pain seems to subside during day but comes back at night. Also reports that the pain seems to travel throughout her body from one shoulder to the next shoulder. She has consulted her hcp. Patient received treatment of prescribed anti inflammatory which helps the pain. The outcome of event joint pain, muscle pain, inflammation was not recovered, and rest of all outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Headache in the frontal lobe region of head lasting about 1 week in duration with episodic headaches throughout entire head lasting approximately 2-4 hours in duration for the next 3 weeks.  Physical sensation of ?cloudiness? throughout the head associated with the headache described above. The ?cloudiness? lasted about 1 week starting 11/17/2021.
This spontaneous report was received from a medical assistant concerning a 12 weeks old male patient. The patients' medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 06-DEC-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ dose 1, lot # L029617, orally, as prophylaxis (Strength, dose and expiration date were not reported), which experienced a temperature excursion (temperature and timeframe were no reported). It was not reported if there were previous temperature excursions. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA006956: US-009507513-1704USA006957: US-009507513-1704USA006958: US-009507513-1701USA005974: US-009507513-1704USA007655: US-009507513-1704USA007664: US-009507513-1704USA007665: US-009507513-1704USA007667: US-009507513-1704USA007668: US-009507513-1704USA007669: US-009507513-1704USA007670: US-009507513-1704USA007671: US-009507513-1704USA007672: US-009507513-1704USA007673:
Brother was walloped after his Moderna Covid-19 vaccine booster.; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Brother was walloped after his Moderna Covid-19 vaccine booster.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced VACCINATION COMPLICATION (Brother was walloped after his Moderna Covid-19 vaccine booster.). At the time of the report, VACCINATION COMPLICATION (Brother was walloped after his Moderna Covid-19 vaccine booster.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The pharmacist reported about the administration of expired moderna vaccine that was given as booster shot to patient. The vaccines was stored in freezer, which was taken out one to two vials and place in fridge each day as needed.  No treatment was given on the patient.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age or gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with PROQUAD (strength, dose, lot #, expiration date and anatomical location were not reported) intramuscularly for prophylaxis; which was reconstituted with sterile water diluent (manufacturer unknown) (lot # and expiration date not reported). No adverse effects reported and no additional information was provided. Follow up information was from the medical assistant on 08-JUN-2017, concerning 4 year old female patient. The patient's concomitant medications included KINRIX. The reporter stated that, on 02-MAY-2017 at 1:52 p.m., the patient was vaccinated with PROQUAD (lot# M044019) dose 2, intramuscular in the left thigh for prophylaxis. Lot number M044019 (rHA) has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live. Additional information is not expected as all schedule follow up information was received. This is an amended report, as corrected. The suspect drug was corrected from Sterile Water (MK 9446) to sterile diluent (MK 9395).
I had Cornea transplant in my eye in my left and right eye and it affected my left cornea transplant. So, now I have 70% vision in my left eye. I do not have full vision in my left eye; I had Cornea transplant in my eye in my left and right eye and it affected my left cornea transplant. So, now I have 70% vision in my left eye. I do not have full vision in my left eye; I received the swelling of the face, left side, tremendously and it is numb; I received the swelling of the face, left side, tremendously and it is numb; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received the first dose of BNT162B2 (PFIZER BIONTECH COVID 19 VACCINE ) via an unspecified route of administration on the left arm on 16Aug2021 at 01:00 (Lot Number: RA1987; Expiration Date: Unknown) at the age of 54-year-old as single dose for COVID-19 immunization. Medical history included depression, arthritis and gout. Investigation assessment was none. Prior vaccination, the patient haven't had the vaccination in 25 years. Concomitant medications included naproxen taken for arthritis and ongoing and mirtazapine. On 18Aug2021 at 01:00, 48 hours after the shot, the patient experienced swelling of the face, left side, tremendously and it is numb. On 20Aug2021, the patient had cornea transplant in eye in left and right eye and it affected left cornea transplant. So, now, the patient had 70% vision in left eye. The patient didn't had full vision in left eye. So, the patient was seeing an eye specialist regarding this matter and trying to get vision back. The patient couldn't wear eye glasses any longer because he gone to get new prescription and everything to correct he cornea. The patient stated "all this because of this Pfizer injection". The patient also stated the anatomical site was left arm and that's why he was affected on the left side of face and he didn't think of that and it's possible. The patient stated the due date of the second dose of BNT162B2 was 01Sep2021. NO treatment was received for vision loss, numbness in face and facial swelling and the patient stated he was going to see the doctor on Monday. The patient have had read the Pfizer paper work. He wanted to known how he get the compensation for his  illness. And he stated that he have seen the program, the Pfizer has compensation for his injury. The outcome of vision loss and corneal disorder was unknown. The outcome of other events was recovering.  No follow-up attempts are possible. No further information is expected.
Patient reported falling asleep in the car on the way home. The next morning  she said that the had a 100.8 Fahrenheit fever and body aches.  She then developed bad nausea that lasted 3 days and is slowly improving.
I had the flu shot and got the flu / Suspected vaccination failure; flu; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Previously administered products included whooping cough vaccine with an associated reaction of pertussis (received on an unknown date).   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows:  The patient had reported the case for himself/herself. The age at vaccination was not reported. The patient had the flu shot and got the flu so he/she did not have it any more. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming Influenza were unknown at the time of reporting. The follow-up would not possible, as no contact details were available.
Earache; she had fever; chills; persistent headache; received her 3rd dose of BNT162b2; This is a spontaneous report received from contactable reporter(s) (Physician and Consumer or other non HCP).  A 60 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Dec2021 (Lot number: FF8841, Expiration Date: Mar2022) at the age of 60 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Left arm, Intramuscular, EL3247), administration date: 17Feb2021, for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE, Left arm), administration date: 10Mar2021, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 01Dec2021, outcome "unknown", described as "received her 3rd dose of BNT162b2"; PYREXIA (non-serious) with onset 02Dec2021 02:30, outcome "unknown", described as "she had fever"; CHILLS (non-serious) with onset 02Dec2021 02:30, outcome "unknown", described as "chills"; HEADACHE (non-serious) with onset 02Dec2021, outcome "unknown", described as "persistent headache"; EAR PAIN (non-serious) with onset 03Dec2021, outcome "unknown", described as "Earache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, chills, headache.  Additional information: Patient had taken Tylenol twice for relief of symptoms.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a male who on approximately 10/10/2001 was vaccinated with varicella vaccine. The physician reported that the pt subsequently presented to the office with a break through case of chicken pox .The pt had about 100 pox that had a short papular phase. The physician indicated that the pt's sister had been immunized three days before the pt and had not become ill. The physician collected isolates from the pt. Additional info has been requested.
Patient called today to state that she had a swollen left arm at the site of injection 48 hours post injection which occurred on 9-12-20. She also stated that just under the injection site, she had about a 4x4 area that was red and had a burning sensation. She was not upset, but wanted us to know, and also inquire if this was normal. She may be contacting her doctor.  Told the patient I will be reporting this reaction and will also be reporting the reaction to VAERS.
pt phoned hlth dept w/rash & itching on 27APR92; pt seen by MD;
Rash that started on the upper extremity and spread to the trunk. The rash is noted to Pediatrics. Symptoms associated with fever, itching and lymphadenopathy. Diagnosis: lymphadenitis, unspecified except Mesenteric-ER on 3-10-07, follow up 3-12-07
Mom called said she wanted it documented that pt had a reaction after the GARDASIL site was sore also came out in hives underarm gave BENEDRYL ok now. Pt reports that about 2 days post GARDASIL #2. The site of the immunization became very itchy, no rash noted at the site. Itching continued with application of BENEDRYL cream. It did not affect her activity. Mom confirmed above, and states itching did subside with a dose of BENEDRYL at beside. Two days later she developed hives under the opposite arm. It disappeared with one dose of oral BENEDRYL. She experienced no other symptoms and has been fine since. Mom did note that itching was documented on the Vaccine Information Sheet. Mom wanted to inform us since the Vaccine Information Sheet did advise reporting of hives. VAERS form will be completed and mailed upon discussion and evaluation by Physician.
Presented with myalgias, fever, nausea, abdominal pain and constipation. Diagnosed with pneumonia due to Covid 19. Remained on room air throughout hospitalization. She was treated with antibiotics and steroids.
LOW ENERGY LEVELS; LOW PLATELETS; LOW HEMOGLOBIN; LOW IRON; BRUISES ON THUMB SPREAD TO ARMS AND LEGS AS WELL; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient did not have any known allergies. Patient did not have any relevant medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 03-APR-2021, the patient experienced bruises on thumb spread to arms and legs as well. On AUG-2021, the patient experienced low platelets, low hemoglobin, and low iron. Laboratory data included: Lab test (NR: not provided) low platelets, low heamoglobin, low iron. On an unspecified date, the patient experienced low energy levels. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low platelets, low hemoglobin, bruises on thumb spread to arms and legs as well, and low energy levels, and the outcome of low iron was not reported. This report was non-serious.
swelling in left arm, hives over arm, back of right shoulder, fast, chest, back, tongue, neck, swelling, short bursts, feverish
When I woke up in the morning on December 24, 2021 I had pain behind my left knee. I discovered a real hard knot there. I brushed it off, and as the day went on it got more sore. The next morning I woke up at 3AM because the knot started throbbing. I went to the ER and discovered that I had a blood clot. The doctor told me to take baby aspirin for 6 weeks. It started dissipating within 2 or 3 days.
COVID Arm - red, heat, rash, itch, swelling for ~7 days post vaccination
2nd day after the 1st vaccination I had some unusual numbness in my left arm and this persisted for a few days and also felt arm pain but that has subsided, my main side effect has been and still is Amenorrhea, my period was completely normal every month prior to the vaccine including march, I have not taken any medications that would cause this or done anything differently and i am only 29, It started immediately after vaccination, I was due my period in April and never got it again in June July or August and have had no period since. I am very afraid of this side effect having lasting effects on my body, and having it not being studied properly in young women vaccinated, I am not pregnant never have been and have been to a doctor about this side effect, I was given no warning this could happen to me and no information or i would have not been vaccinated. 1st dose of Covid Pfizer vaccine April 12th 2021 and 2nd dose on monday May 3rd 2021, and I have never had covid or been infected with covid and I am physically healthy prior to vaccination.
lt arm red & swollen for several days;8FEB97 afeb 101 given APAP on 9FEB97 4AM parents heard crib against wall & checked on child;pt lifeless, blue w/eyes rolled back-called 911 & advised to perform CPR;02 given later
experienced numbness in her mouth that subsided after about 1 hour; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Formulation: Solution for injection, Lot number: ER8733), via an unspecified route of administration on 01Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included food allergy and takes immunosuppressive medicine. The patient concomitant medication was not reported. The patient experienced numbness in her mouth that subsided after about 1 hour on 01Apr2021. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Mom states child was dizzy, nauseated and right Del red swollen, redness under arm as well and is painful.
Initial misuse report received from a non healthcare professional on 16 April 2013. A 6-month-old patient had received ADACEL vaccine instead of DAPTACEL vaccine as of three doses in the series. No adverse event was reported. List of documents held by sender: none.
Injection site- warmth and redness. Systemic symptoms- fever, body aches, fatigue, decreased appetite, urinary frequency.
random sharp pain in left temple only lasting 30-60 seconds; Ice pick migraines; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 14Apr2021 at 12:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation.The patient did not have any relevant medical history, never had migraines before either. The patient had no allergies to medications, food or other products. The patient did not receive any other medications in two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 19:00, the patient felt random sharp pain in his left temple which only lasted for 30-60 seconds. The patient never had migraines before and he believed it was commonly referred as ice pick migraines. They have been reoccurring regularly since the day the patient was vaccinated. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event random sharp pain in left temple and ice pick migraines was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 23-OCT-2013 at 17:30, ZOSTAVAX lot # J004268 was exposed to -14C for an estimated total time out of range of 10.0 hours. On 25-OCT-2013 at 18:30, ZOSTAVAX lot # J004268 was exposed to an exact T not recorded but noted as equal to or >12C for an estimated total time out of range of 10.5 hours. On 01-NOV-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number J004268, Exp. Date: 12-JUL-2014). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.